Modification of the immune response against hepatitis B virus by the human immunodeficiency virus
✍ Scribed by G. Hess; S. Rossol; R. Voth; K. C. Weber; K. -H. Meyer zum Büschenfelde
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 458 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Seventy-eight patients with congenital coagulation disorders were treated with hepatitis B vaccine either subcutaneously or intradermally. All the children (eight vaccinated subcutaneously and eight vaccinated intradermally) responded. Seventeen of 19 (goo/,) anti-HIV-negative adults vaccinated subc
Recent studies have demonstrated that commercial preparations of hepatitis B immune globulin often contain antibody to the human immunodeficiency virus. The presence of this antibody has aroused concerns that treatment with hepatitis B immune globulin might passively induce human immunodeficiency vi
Individuals with chronic hepatitis B virus (HBV)